MedTrace Logo

The Heidelberg Engineering BI US Evaluation Study

NCT03578302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2025-06-12

No results posted yet for this study

Summary

Evaluation of defined parameters measured in pathological and non-pathological eyes with the Heidelberg BI

Conditions

  • Normal Eyes
  • Eye Abnormalities

Interventions

DEVICE

BI Anterior Segment Mode

Single eye measurement in Anterior Segment Mode

DEVICE

BI Anterior Segment and IOL Biometry Mode

Eye measurement 3 times with and without dilation in IOL biometry and Anterior Segment mode

Sponsors & Collaborators

  • Heidelberg Engineering GmbH

    lead INDUSTRY

Principal Investigators

  • Mitchell Dul, OD · State University of New York College of Optometry

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-22
Primary Completion
2018-12-03
Completion
2018-12-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03578302 on ClinicalTrials.gov